Dr. Giuseppe Provenzano @RheumatolTher , et al . recent article on “Non-medical switching from originators to… https://t.co/b5LGh4LQaM
Archives
Our latest podcast features Prof Edouard Louis dis
Our latest podcast features Prof Edouard Louis discussing the results of the SPARE trial of infliximab or immunosup… https://t.co/3LBfqlRc9O
On today’s episode of Adventures woth Sherlock C
On today’s episode of Adventures woth Sherlock Crohns, Sherlock preps for a colonoscopy and waits patiently for his… https://t.co/E6MB7KVW7H
One of the services we offer are #biosimilars. Bio
One of the services we offer are #biosimilars.
Biologics (large and usually complex molecules produced from livin… https://t.co/FRjKhLiI4O
Have you taken our IBD diet survey? https://t.co/5
Have you taken our IBD diet survey?
Six molecules in two years!! @enzenebio making #bi
Six molecules in two years!! @enzenebio making #biosimilars more affordable in the Indian market https://t.co/5WLcuqibse
#Zarxio was the first product approved in the US a
#Zarxio was the first product approved in the US as a biosimilar in 2015. To date, FDA has approved four… https://t.co/VxMfJj9uAX
“We are creating the solid ground for the future,
“We are creating the solid ground for the future, and it is very exciting.”
Timely podcast with all the #biosimilars happening
Timely podcast with all the #biosimilars happenings! 🎧 in! https://t.co/dpZsfPiGmy
We are excited to join industry leaders at this ye
We are excited to join industry leaders at this year’s World Biosimilars Congress USA to discuss the current… https://t.co/NdPowVE11h